Search filters

List of works by Stephen Devereux

ALK-positive large B-cell lymphoma with strong CD30 expression; a diagnostic pitfall and resistance to brentuximab and crizotinib

scientific article published on 19 July 2016

Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial

scientific article published on 09 April 2012

Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital

scientific article published on 28 September 2014

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

scientific article published on 11 September 2003

CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment

scientific article published on 07 March 2008

Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival

scientific article published on 20 August 2007

Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9

scientific article published on 14 May 2011

False positive results of galactomannan ELISA assay in haemato-oncology patients: a single centre experience

scientific article published on 23 January 2007

How I treat patients with relapsed chronic lymphocytic leukaemia.

scientific article

Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML

scientific article published on 21 September 2009

Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT)

scientific article published on 23 October 2006

Increase in allergy following donor lymphocyte infusions

scientific article published on 01 May 2006

Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation andDe novoGene Transcription ⬇️

scientific article published on August 24, 2010

Koebnerizing sclerodermatous graft-versus-host disease caused by donor lymphocyte infusion and interferon-alpha

scientific article published on 01 September 2006

Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.

scientific article published in December 2006

Laser capture microscopy as a tool for the assessment of lineage-specific chimaerism from archived blood and bone marrow films

scientific article published on 01 February 2007

Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphoma

scientific article published on 18 March 2014

Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia secondary to myelodysplastic syndrome

scientific article published on 08 November 2013

NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome

scientific article published on 5 July 2016

Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre study.

scientific article published on 16 January 2017

Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.

scientific article published on 3 March 2008

Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes

scientific article published on 21 December 2012

Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes.

scientific article published on 25 August 2006

Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data.

scientific article

Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).

scientific article published on 29 December 2011

Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration

scientific article

Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition

scientific article published on 28 October 2014

Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy

scientific article published on 01 September 2006

Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions.

scientific article

Rho and Rap guanosine triphosphatase signaling in B cells and chronic lymphocytic leukemia

scientific article published on 31 December 2013

Sarcoidosis and haematological malignancies: is there an association?

scientific article published on 26 February 2008

Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges

scientific article published on 05 April 2007

The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma.

scientific article

Tumor supernatant from myeloid malignancies inhibits T-cell apoptosis and cell cycle entry independently.

scientific article published in September 2005

Tumor-derived IL-6 may contribute to the immunological defect in CLL

scientific article published on 01 November 2007

Two-faced T cells in CLL.

scientific article

Updated Efficacy and Safety from the Phase 3 Resonate-2 Study: Ibrutinib As First-Line Treatment Option in Patients 65 Years and Older with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia

Scientific article published on 2 Dec 2016

Paulina is supported by:

About Paulina

Help